{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:04Z","timestamp":1788782884578,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tmrv.2026.151019","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T21:54:04Z","timestamp":1782683644000},"page":"151019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should Transfusions of Donated G6PD-Deficient Donor Red Blood Cells Be Restricted to Improve Patient Safety? A Critical Review of the Current Literature"],"prefix":"10.1016","volume":"40","author":[{"given":"Matthew S","family":"Karafin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-680X","authenticated-orcid":false,"given":"Richard O","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.tmrv.2026.151019_bib0001","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2026.151019_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2013.11.022","article-title":"Inborn defects in the antioxidant systems of human red blood cells","volume":"67","author":"van Zwieten","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151019_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1708111","article-title":"Favism and glucose-6-phosphate dehydrogenase deficiency","volume":"378","author":"Luzzatto","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2026.151019_bib0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","article-title":"Glucose-6- phosphate dehydrogenase (G6PD) mutations database: review of the \"old\" and update of the new mutations","volume":"48","author":"Minucci","year":"2012","journal-title":"Blood Cells Mol Dis"},{"issue":"8","key":"10.1016\/j.tmrv.2026.151019_bib0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2471\/BLT.23.291224","article-title":"New WHO classification of genetic variants causing G6PD deficiency","volume":"102","author":"Luzzatto","year":"2024","journal-title":"Bull World Health Organ"},{"issue":"18","key":"10.1016\/j.tmrv.2026.151019_bib0006","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151019_bib0007","first-page":"27","article-title":"Red blood cell storage lesion: causes and potential clinical consequences","volume":"17","author":"Yoshida","year":"2019","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.tmrv.2026.151019_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/vox.12068","article-title":"Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks","volume":"105","author":"Francis","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2026.151019_bib0009","series-title":"Blood donor selection: guidelines on assessing donor suitability for blood donation","author":"Stainsby","year":"2012"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151019_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1537-2995.2012.03765.x","article-title":"Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service","volume":"53","author":"Francis","year":"2013","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151019_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/trf.16806","article-title":"Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease","volume":"62","author":"Yee","year":"2022","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.tmrv.2026.151019_bib0012","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MOH.0000000000000455","article-title":"The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease","volume":"25","author":"Karafin","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2026.151019_bib0013","first-page":"47","article-title":"Erythrocytic glucose-6-phosphate dehydrogenase deficiency as a problem in the selection of blood donors","volume":"8","author":"Tizianello","year":"1963","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.tmrv.2026.151019_bib0014","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1537-2995.2008.01642.x","article-title":"AuBuchon. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials","volume":"48","author":"Dumont","year":"2008","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151019_bib0015","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1172\/JCI133530","article-title":"Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion","volume":"130","author":"Francis","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.tmrv.2026.151019_bib0016","first-page":"930","article-title":"The poststorage viability of glucose-6-phosphate dehydrogenase-deficient erythrocytes","volume":"75","author":"Orlina","year":"1970","journal-title":"J Lab Clin Med"},{"issue":"Suppl.1","key":"10.1016\/j.tmrv.2026.151019_bib0017","article-title":"G6PD-deficient units should be avoided in chronically exchanged patients with sickle cell disease","volume":"40","author":"Karafin","year":"2025","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2026.151019_bib0018","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025019005","article-title":"Red cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity","author":"Yee","year":"2026","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.tmrv.2026.151019_bib0019","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/tme.12871","article-title":"Randomized controlled trial of glucose-6-phosphate dehydrogenase deficient versus non-deficient red blood cell transfusion in patients with hypoproliferative anaemia","volume":"32","author":"Krajibthong","year":"2022","journal-title":"Transfus Med"},{"issue":"1","key":"10.1016\/j.tmrv.2026.151019_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152598","article-title":"Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness","volume":"7","author":"Roubinian","year":"2022","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151019_bib0021","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ajh.25051","article-title":"Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease","volume":"93","author":"Sagiv","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2026.151019_bib0022","article-title":"Genetic variation of human G6PD impacts red blood cell transfusion efficacy","author":"Karafin","year":"2025","journal-title":"bioRxiv"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632600060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632600060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:13Z","timestamp":1788779833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779632600060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S088779632600060X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151019","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Transfusions of Donated G6PD-Deficient Donor Red Blood Cells Be Restricted to Improve Patient Safety? A Critical Review of the Current Literature","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151019"}}